Credit Suisse’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

Credit Suisse’s Portfolio CINC Stock Details CINC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-11,491	Closed	-$141K	–	3934
2022 Q4	$141K	Sell	11,491 -552	-5%	-$13.2K	﹤0.01%	3266
2022 Q3	$395K	Buy	12,043 +1,850	+18%	+$52.3K	﹤0.01%	2933
2022 Q2	$192K	Buy	+10,193	New	+$195K	﹤0.01%	3343

Credit Suisse's CINC Position: Q1 2023 in Review

Credit Suisse sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 11,491 shares — an estimated $141K sold.

Credit Suisse first reported a position in CINC in Q2 2022 and held it in 3 quarters. The position peaked at $395K in Q3 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

Credit Suisse reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Credit Suisse sold 11,491 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $141K.
Credit Suisse first reported a position in CinCor Pharma, Inc. Common Stock in Q2 2022 and held it in 3 quarters.
Credit Suisse's CinCor Pharma, Inc. Common Stock position peaked at $395K in Q3 2022.
0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on Credit Suisse's 13F filing for Q1 2023, filed 10 May 2023.